Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
GBCI reports after market close, meaning Day 0 captures anticipatory trading before results are known, while Day +1 reflects the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-23 | +$0.51 (+1.04%) | $0.95 (1.94%) | -$0.65 (-1.32%) | $2.41 (4.88%) |
| 2026-01-22 | +$0.20 (+0.40%) | $1.18 (2.38%) | -$1.87 (-3.75%) | $3.13 (6.28%) |
| 2025-10-16 | -$2.97 (-6.18%) | $3.46 (7.21%) | -$1.11 (-2.46%) | $3.44 (7.64%) |
| 2025-07-24 | -$1.32 (-2.88%) | $1.25 (2.71%) | +$0.75 (+1.68%) | $1.69 (3.79%) |
| 2025-04-24 | +$0.80 (+1.91%) | $1.37 (3.26%) | -$1.81 (-4.25%) | $2.28 (5.35%) |
| 2025-01-23 | -$0.28 (-0.54%) | $0.85 (1.65%) | -$0.75 (-1.46%) | $2.40 (4.67%) |
| 2024-10-24 | +$0.60 (+1.27%) | $1.40 (2.97%) | +$1.85 (+3.88%) | $2.04 (4.26%) |
| 2024-07-18 | -$0.83 (-1.88%) | $1.88 (4.25%) | -$0.24 (-0.55%) | $1.75 (4.04%) |
| Avg Abs Move | 2.01% | 3.30% | 2.42% | 5.11% |
Historical price behavior shows GBCI typically experiences moderate volatility around earnings, with an average absolute Day 0 move of 2.01% and Day +1 move of 2.42%. The intraday ranges are wider, averaging 3.30% on Day 0 and 5.11% on Day +1, indicating significant intraday swings even when closing moves are more contained.
The most recent earnings on April 23, 2026 saw relatively muted action—up 1.04% on Day 0 and down 1.32% on Day +1—despite the company beating estimates. In contrast, the October 2025 report triggered a sharp 6.18% Day 0 decline, the largest move in the dataset, likely reflecting the disappointing Q3 results. The January 2026 report produced a 3.75% Day +1 decline despite a modest Day 0 gain, suggesting negative guidance or commentary overshadowed the headline number.
Investors should anticipate a potential move in the 2-5% range based on historical patterns, with the direction heavily dependent on whether GBCI can validate the aggressive 68.89% year-over-year growth estimate and provide confidence in the sustainability of the earnings inflection.
Analysts maintain a bullish stance on GBCI heading into earnings, with an average recommendation of 4.14 (solidly in Buy territory) based on seven analysts. The breakdown shows 3 Strong Buys, 2 Moderate Buys, and 2 Holds, with no sell ratings. This distribution reflects broad confidence in the bank's prospects, though the presence of two Hold ratings suggests some caution remains.
The consensus price target of $56.58 implies 10.6% upside from the current price of $51.17, with the range spanning from $54.00 to $60.00. The relatively tight target range indicates analysts are largely aligned on valuation, with the high-end target suggesting the most optimistic analysts see nearly 17% upside potential.
Sentiment has remained unchanged over the past month, with the rating distribution and average recommendation holding steady at 4.14. This stability suggests analysts are waiting for the Q2 results to either confirm the earnings acceleration thesis or prompt a reassessment. The lack of recent upgrades or downgrades indicates the Street is positioned but not aggressively leaning into the story ahead of this critical earnings test.
The Barchart Technical Opinion shows GBCI at 88% Buy currently, down from 100% Buy a week ago but improved from 80% Buy a month ago. This reflects a stock that has built positive momentum over the past month but experienced a slight pullback in the most recent sessions.
Timeframe Analysis:
Trend Characteristics: The combination of Strong strength and Average direction suggests GBCI is in a well-established uptrend but not overextended, providing a relatively neutral technical backdrop heading into the earnings release.
The stock is trading at $51.17, positioned above its 50-day ($49.37), 100-day ($47.87), and 200-day ($46.84) moving averages—a bullish alignment that confirms the longer-term uptrend. However, the current price sits below the 5-day ($52.76), 10-day ($52.29), and 20-day ($51.94) moving averages, indicating recent short-term weakness or consolidation.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $52.76 | 50-Day MA | $49.37 |
| 10-Day MA | $52.29 | 100-Day MA | $47.87 |
| 20-Day MA | $51.94 | 200-Day MA | $46.84 |
The technical setup heading into earnings is constructive but not euphoric. GBCI has pulled back from recent highs near $52.76 but remains well-supported by rising longer-term moving averages, suggesting the stock has room to run on a positive earnings surprise without being overbought. The 50-day average at $49.37 represents the first meaningful support level if results disappoint. With the stock trading roughly in line with its 20-day average, the technical picture appears balanced—neither stretched nor broken—allowing the earnings results and guidance to be the primary driver of the next directional move.